Recent Publications by Johnson and Johnson: |
Fluorescence and coloration of grey hair.
Grey hair samples were collected from 11 individuals and separated into... | 18th November, 2009
| Johnson and Johnson, Consumer Products Division, Skillman, NJ, USA.
| Int J Cosmet Sci. 2009 Oct;31(5):347-59.
DOI Direct Link |
Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.
BACKGROUND: Hematopoietic stem cells (HSC), in particular mobilized... | 11th November, 2009
| Johnson and Johnson Research Pty Ltd., Eveleigh, New South Wales,
| PLoS One. 2009 Jul 30;4(7):e6461.
DOI Direct Link |
Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success.
BACKGROUND: Multiple short hairpin RNA (shRNA) gene therapy strategies are... | 3rd November, 2009
| Johnson and Johnson Research Pty Ltd, Level 4 Biomedical Building,
| Virol J. 2009 Oct 30;6:184.
DOI Direct Link |
Pharmacometrics-Based Dose Selection of Levofloxacin as a Treatment for Post-Exposure Inhalational Anthrax in Children.
Levofloxacin was recently (May 2008) approved by U.S. Food and Drug... | 28th October, 2009
| Division of Pharmacometrics, Office of Clinical Pharmacology, Center for
| Antimicrob Agents Chemother. 2009 Oct 26.
DOI Direct Link |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
BACKGROUND: MicroRNAs (MiRNAs) are short non-coding RNAs that control... | 22nd October, 2009
| Johnson and Johnson Research Pty Ltd, Eveleigh, NSW, Australia.
| BMC Cancer. 2009 Oct 20;9:374.
DOI Direct Link |
Sequence determinants of innate immune activation by short interfering RNAs.
BACKGROUND: Short interfering RNAs (siRNAs) have been shown to induce... | 22nd October, 2009
| Johnson and Johnson Research Pty Ltd, Strawberry Hills, NSW, Australia.
| BMC Immunol. 2009 Jul 24;10:40.
DOI Direct Link |
Role of Janus kinase-2 in IgE receptor-mediated leukotriene C(4) production by mast cells.
We have previously shown that Janus kinase 3, a member of the family of... | 20th October, 2009
| Johnson and Johnson Consumer and Personal Products Worldwide, Skillman,
| Biochem Biophys Res Commun. 2009 Oct 14.
DOI Direct Link |
96 shRNAs designed for maximal coverage of HIV-1 variants.
BACKGROUND: The RNA interference (RNAi) pathway is a mechanism of... | 6th October, 2009
| Johnson and Johnson Research Pty Ltd, Australian Technology Park,
| Retrovirology. 2009 Jun 4;6:55.
DOI Direct Link |
Primary leukocyte screens for innate immune agonists.
The innate immune system of mammals is a key defense mechanism against... | 1st October, 2009
| Johnson and Johnson Research Pty Ltd, Strawberry Hills NSW, Australia.
| J Biomol Screen. 2009 Jul;14(6):723-30. Epub 2009 Jun 12.
DOI Direct Link |
The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines.
Please cite this paper as: The role of keratinocyte growth factor in... | 29th September, 2009
| The Johnson and Johnson Skin Research Center, Consumer Product Worldwide,
| Exp Dermatol. 2009 Sep 23.
DOI Direct Link |
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.
ABSTRACT: BACKGROUND: Opioid analgesics have proven efficacy in the... | 17th September, 2009
| Johnson and Johnson Pharmaceutical Research Division Corporation, 6500
| BMC Palliat Care. 2009 Sep 15;8:14.
DOI Direct Link |
Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortex.
Norfluoxetine is the most important active metabolite of the widely used... | 6th August, 2009
| Johnson and Johnson Pharmaceutical Research and Development, L. L. C.,
| Pharmacol Biochem Behav. 2009 May;92(3):469-73. Epub 2009 Feb 5.
DOI Direct Link |
Heat-killed Propionibacterium acnes is capable of inducing inflammatory responses in skin.
Please cite this paper as: Heat-killed Propionibacterium acnes is capable... | 25th July, 2009
| Preclinical Pharmacology, Skin Research Center, Johnson and Johnson
| Exp Dermatol. 2009 Jul 14.
DOI Direct Link |
A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice.
BACKGROUND: The mammalian target of rapamycin protein (mTOR) is an... | 22nd May, 2009
| Inflammation Research Team, Drug Discovery, Johnson and Johnson
| BMC Immunol. 2009 May 20;10:28.
DOI Direct Link |
Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease.
BACKGROUND: Secretory leucocyte protease inhibitor (SLPI), which is... | 30th April, 2009
| Johnson and Johnson Pharmaceutical Research and Development, Spring House,
| Clin Exp Allergy. 2009 Aug;39(8):1179-86. Epub 2009 Apr 7.
DOI Direct Link |
